Manhattan Research Releases Physician Digital Media Planning Guide

Manhattan ResearchWhile most marketers have accepted that nearly all physicians are online today, the more difficult part is figuring out where to find these physicians on the World Wide Web. Finding the right promotional mix for connecting with physicians can be a challenging proposition, as physicians use third-party sites - such as the WebMD Professional Network, the New England Journal of Medicine, or specialty specific sites - more frequently than they use pharma-owned properties. As a result, brands realize that it is essential to connect with physicians through a variety of online professional resources - but figuring out where to find these physicians can prove difficult.

"Physician Digital Media Landscape: Connecting with Physicians Through Online Professional Resources," is part of Manhattan Research's ePharma Physician® market research and advisory service and provides a roadmap for physician marketers and media planners. The report explores the top professional medical websites, specialty sites, print and online medical journals, and professional email newsletters for primary care physicians, pediatricians, oncologists, cardiologists, gastroenterologists, infectious disease/HIV physicians, rheumatologists, and OB/GYNs. "Physician Digital Media Landscape" also includes interviews with industry experts, case studies, and a look at the future of physician marketing.

"This guide is an invaluable resource for anyone interested in understanding how physicians gather information online today," says Meredith Ressi, Vice President of Research at Manhattan Research. "Many companies are struggling to understand the appropriate promotional mix across the vast range of online resources used by physicians. This data shows the professional sources physicians rely on to gather professional medical information."

Report Outline
Title: Physician Digital Media Landscape: Connecting with Physicians through Online Professional Resources

Introduction
Physician Digital Media Outlook for Primary Care Physicians, Pediatricians, Oncologists, Cardiologists, Gastroenterologists, Infectious Disease/HIV Physicians, Rheumatologists, and OB/GYNs

  • Professional Medical Websites
  • Specialty Websites
  • Professional Journals
  • Professional Email Newsletters

Top Online Physician Professional Online Resource Summary

Physician Digital Media Outlook and Strategy

Conclusion and Key Takeaways

For an excerpt from the module and more information about its contents, please visit: www.manhattanresearch.com/products/Research_Modules/Physician/physician-digital-media-landscape.aspx

Access to the "Physician Digital Media Landscape" research module is immediately available to subscribers of Manhattan Research's ePharma Physician® v9.0 market research and strategic advisory service. For more information about subscribing to this service and gaining access to the in-depth physician market data and analysis, visit www.manhattanresearch.com/products/Strategic_Advisory/ePP.

About ePharma Physician® v9.0
ePharma Physician® v9.0 was conducted via online survey methodology in Q2 2009 among 1,517 online practicing U.S. physicians. Since 2002, the study has determined the leading online physician destinations based on the number of physician visitors as well as the content satisfaction of those who visit. ePharma Physician® gives insight to the physician digital resource and communication mix of over twenty specialist segments, including topics such as:

  • Product and corporate pharmaceutical websites
  • Specialty-specific sites, online journals, newsletters, and online conferences
  • Interactive detailing, live remote rep, customer service portals, and email communication
  • Web 2.0 technologies such as blogs, podcasts, wikis, and online communities

For additional product and subscription information, please visit www.manhattanresearch.com/products/Strategic_Advisory/ePP.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.decisionresourcesinc.com.

Most Popular Now

Regorafenib to be tested in brain cancer patients …

Bayer announced that the regorafenib arm of the platform trial "GBM AGILE" (Glioblastoma Adaptive Global Innovative Learning Environment) opened for enrollment in the US ...

Sanofi and Google to develop new healthcare Innova…

Sanofi and Google will establish a new virtual Innovation Lab with the ambition to radically transform how future medicines and health services are delivered by tapping i...

Bristol-Myers Squibb provides update on pending me…

Bristol-Myers Squibb Company (NYSE: BMY) today provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation (NASDAQ: ...

Breztri Aerosphere (PT010) approved in Japan for p…

AstraZeneca announced that Breztri Aerosphere (budesonide/glycopyrronium/ formoterol fumarate), formerly PT010, has been approved in Japan as a triple-combination therapy...

Artificial DNA can control release of active ingre…

A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was o...

Human-on-a-chip model tests cancer drug efficacy a…

A reconfigurable "body-on-a-chip" model could transform drug development by simultaneously measuring compound efficacy and toxicity, for both target cells and other organ...

Pathogen engineered to self-destruct underlies can…

A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors. A feature of the vaccine causes these bacteria to self-dest...

Novartis successfully completes acquisition of Xii…

Novartis today announced that it has completed its acquisition of Xiidra® (lifitegrast ophthalmic solution) 5%, the first and only prescription treatment approved to trea...

LEO Pharma completes the acquisition of Bayer’s pr…

LEO Pharma and Bayer announced today the achievement of the relevant closing conditions to allow the transfer of Bayer’s global prescription dermatology business to LEO P...

How gastric stem cells fight bacteria

Stem cells are not only key players in tissue regeneration, they are also capable of taking direct action against bacteria. This is the finding of a study conducted by re...

New study showing drug prolongs life for patients …

Women with ovarian cancer who have undergone four or more rounds of chemotherapy typically haven't had much hope that another treatment option will lengthen their lives i...

Pfizer completes acquisition of Therachon

Pfizer Inc. (NYSE: PFE) announced the successful completion of its acquisition of the privately held clinical-stage biotechnology company Therachon Holding AG. Under the ...